Cargando…
mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes Mellitus (DM) Patients’ Blood Sugar Levels
This study was conducted to test the effectiveness of a particular bitter melon peptide (BMP), with a specific sequence of 19 amino acids (mcIRBP-19), in regulating diabetic patients’ blood glucose. In order to test the product with the specially processed BMP, a total of 142 diabetic patients were...
Autores principales: | Hsu, Pang-Kuei, Pan, Frank F. C., Hsieh, Ching-Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281988/ https://www.ncbi.nlm.nih.gov/pubmed/32354072 http://dx.doi.org/10.3390/nu12051252 |
Ejemplares similares
-
A randomized, double-blind, placebo-controlled trial to evaluate the hypoglycemic efficacy of the mcIRBP-19-containing Momordica charantia L. fruit extracts in the type 2 diabetic subjects
por: Yang, Yi-Sun, et al.
Publicado: (2022) -
Exploring the Factors Affecting Bitter Melon Peptide Intake Behavior: A Health Belief Model Perspective
por: Pan, Frank, et al.
Publicado: (2020) -
Evaluation of acute and sub-chronic toxicity of bitter melon seed extract in Wistar rats
por: Chung, Wan-Yu, et al.
Publicado: (2022) -
Reply to Redmond and McLysaght: Uncertainty in the origin of amphioxus IRBP homologs
por: Kalluraya, Chinmay A., et al.
Publicado: (2023) -
The effect of bitter melon (Mormordica charantia) in patients with diabetes mellitus: a systematic review and meta-analysis
por: Yin, R V, et al.
Publicado: (2014)